Proteomic Analysis of Chemonaïve Pediatric Osteosarcomas and Corresponding Normal Bone Reveals Multiple Altered Molecular Targets
- 3 June 2009
- journal article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 8 (8), 3882-3888
- https://doi.org/10.1021/pr900113w
Abstract
With a view to identify the proteins involved in transformation, metastasis or chemoresistance in pediatric osteosarcoma, we carried out a new experimental approach based on comparison of the proteomic profile of paired samples of osteosarcoma and normal bone tissues from the same patient. The proteomic profiles of five pairs of cell lines (normal vs tumoral) were obtained by two-dimensional difference gel electrophoresis. We detected 56 differential protein spots (t test, p < 0.05). Subsequent protein characterization by nano-LC-ESI-MS/MS enabled us to identify some of these proteins, 16 of which were chosen on the basis of the change of their relative abundance between osteosarcomas and paired normal bones and also because their involvement was supported by the genomic analysis. Two of the 16 proteins, Alpha-crystallin B chain (CRYAB) and ezrin (EZR1), were selected for further studies: an immunohistochemical analysis of a TMA (tissue microarray) and real-time PCR for a set of 14 osteosarcoma/normal-bone pairs. The results of this second tier of studies confirmed that there were significant increases in the amounts of CRYAB and ezrin, especially in advanced stages of the disease. Our overall conclusion is that proteomic profiling of paired samples of osteosarcoma and normal bone tissues from the same patient is a practicable and potentially powerful way of initiating and proceeding with a search for proteins and genes involved in pediatric osteosarcoma.Keywords
This publication has 21 references indexed in Scilit:
- Global Protein-expression Analysis of Bone and Soft Tissue SarcomasClinical Orthopaedics and Related Research, 2008
- A review of clinical and molecular prognostic factors in osteosarcomaZeitschrift für Krebsforschung und Klinische Onkologie, 2007
- Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcomaCurrent Opinion in Oncology, 2007
- Molecular Pathogenesis of OsteosarcomaDNA and Cell Biology, 2007
- Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondromaProteomics, 2006
- Gene amplifications in osteosarcoma-CGH microarray analysisGenes, Chromosomes and Cancer, 2004
- Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumorsCancer Genetics and Cytogenetics, 2003
- Connexin43 Deficiency Causes Delayed Ossification, Craniofacial Abnormalities, and Osteoblast DysfunctionThe Journal of cell biology, 2000
- Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2Journal of Cellular Biochemistry, 1997
- Cytogenetic findings in 73 osteosarcoma specimens and a review of the literatureCancer Genetics and Cytogenetics, 1997